LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma announced today that pre-clinical data for SubQ-8 were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World ...
Executives from AbbVie (NYSE:ABBV) outlined upcoming clinical milestones and development priorities across hidradenitis ...
Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, reimbursement complexities, and insufficient economic incentives slow the ...
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma announced that an update on the clinical development plan and pre-clinical data with SubQ-8 were presented today in a scientific symposium at the 27th ...
Panelists discuss how the rapid adoption of subcutaneous (SubQ) oncology therapies creates challenges around clinical autonomy, infusion center sustainability, patient experience, and reimbursement ...
Medroxyprogesterone acetate 104mg/0.65mL; SC inj; contains parabens. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation ...
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed at ensuring its own PD-1 stalwart doesn’t miss out on the action. GSK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results